AS Watson, the parent company of the UK health and beauty chain Superdrug, is accelerating preparations for a stock market flotation valued at approximately £22 billion.
The company aims to complete the initial public offering before the end of the year, marking one of the largest potential listings in the consumer sector this cycle.
Dr Malina Ngai, the chief executive of AS Watson, is currently in London to present the investment case to potential backers.
Ngai, a former athlete turned retail executive, is spearheading the effort to bring the publicly traded subsidiary of CK Hutchison Holdings to the market.
The presentation in the City underscores the company's confidence in the current market environment for large-cap consumer listings.
The proposed valuation places AS Watson among the most significant retail IPOs in recent years.